메뉴 건너뛰기




Volumn 9, Issue 3, 2013, Pages 418-426

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: A post hoc analysis of the GREACE study

Author keywords

Age; Cardiovascular disease; Chronic kidney disease; GREek atorvastatin and coronary heart disease evaluation; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

EID: 84879831859     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.35424     Document Type: Article
Times cited : (44)

References (63)
  • 1
    • 79958192032 scopus 로고    scopus 로고
    • Lipid-lowering drug therapy in elderly patients
    • Berthold HK, Gouni-Berthold I. Lipid-lowering drug therapy in elderly patients. Curr Pharm Des 2011; 17: 877-93.
    • (2011) Curr Pharm Des , vol.17 , pp. 877-893
    • Berthold, H.K.1    Gouni-Berthold, I.2
  • 3
    • 0344653659 scopus 로고    scopus 로고
    • Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
    • Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96: 4211-8. (Pubitemid 28007446)
    • (1997) Circulation , vol.96 , Issue.12 , pp. 4211-4218
    • Miettinen, T.A.1    Pyorala, K.2    Olsson, A.G.3    Musliner, T.A.4    Cook, T.J.5    Faergeman, O.6    Berg, K.7    Pedersen, T.8    Kjekshus, J.9
  • 5
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-57.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 6
    • 34447274822 scopus 로고    scopus 로고
    • Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
    • Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK; Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low-dose atorvastatin in patients 65 s of age or older with stable coronary heart disease. Ann Intern Med 2007; 147: 1-9. (Pubitemid 351664628)
    • (2007) Annals of Internal Medicine , vol.147 , Issue.1 , pp. 1-9
    • Wenger, N.K.1    Lewis, S.J.2    Herrington, D.M.3    Bittner, V.4    Welty, F.K.5
  • 7
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 8
    • 84880047072 scopus 로고    scopus 로고
    • In patients with chronic stable angina, secondary prevention appears better in the very old compared to younger patients: The Coronary Artery Disease in gENeral practiCE (CADENCE) Substudy
    • Epub ahead of print
    • Rajendran S, Visvanathan R, Tavella R, Weekes AJ, Morgan C, Beltrame JF. In patients with chronic stable angina, secondary prevention appears better in the very old compared to younger patients: The Coronary Artery Disease in gENeral practiCE (CADENCE) Substudy. Heart Lung Circ 2012 Epub ahead of print.
    • (2012) Heart Lung Circ
    • Rajendran, S.1    Visvanathan, R.2    Tavella, R.3    Weekes, A.J.4    Morgan, C.5    Beltrame, J.F.6
  • 9
    • 70350129073 scopus 로고    scopus 로고
    • Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: A comparison of sub-groups by age
    • Rahilly-Tierney CR, Lawler EV, Scranton RE, Gaziano JM. Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of sub-groups by age. Circulation 2009; 120: 1491-7.
    • (2009) Circulation , vol.120 , pp. 1491-1497
    • Rahilly-Tierney, C.R.1    Lawler, E.V.2    Scranton, R.E.3    Gaziano, J.M.4
  • 10
    • 85031966150 scopus 로고    scopus 로고
    • Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: The population-based AGESReykjavik Study
    • Olafsdottir E, Aspelund T, Sigurdsson G, et al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGESReykjavik Study. BMJ Open 2011; 1: e000132.
    • (2011) BMJ Open , vol.1
    • Olafsdottir, E.1    Aspelund, T.2    Sigurdsson, G.3
  • 11
    • 0036023515 scopus 로고    scopus 로고
    • Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
    • Athyros VG, Papageorgiou AA, Mercouris BR, et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002; 18: 220-8.
    • (2002) Curr Med Res Opin , vol.18 , pp. 220-228
    • Athyros, V.G.1    Papageorgiou, A.A.2    Mercouris, B.R.3
  • 12
    • 0035897696 scopus 로고    scopus 로고
    • The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
    • The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 13
    • 0037145887 scopus 로고    scopus 로고
    • Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients
    • DOI 10.1016/S0735-1097(02)02477-4, PII S0735109702024774
    • Allen Maycock CA, Muhlestein JB, Horne BD, et al.; Intermountain Heart Collaborative Study. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002; 40: 1777-85. (Pubitemid 35341956)
    • (2002) Journal of the American College of Cardiology , vol.40 , Issue.10 , pp. 1777-1785
    • Allen, M.C.A.1    Muhlestein, J.B.2    Horne, B.D.3    Carlquist, J.F.4    Bair, T.L.5    Pearson, R.R.6    Li, Q.7    Anderson, J.L.8
  • 15
    • 0032229826 scopus 로고    scopus 로고
    • Epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (12 Suppl): S16-23.
    • (1998) J Am Soc Nephrol , vol.9 , Issue.12 SUPPL.
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3
  • 16
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
    • (2004) N Engl J Med , vol.351 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3    McCulloch, C.E.4    Hsu, C.Y.5
  • 19
    • 1542298565 scopus 로고    scopus 로고
    • The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
    • DOI 10.1136/jcp.2003.012989
    • Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A sub-group analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004; 57: 728-34. (Pubitemid 38901488)
    • (2004) Journal of Clinical Pathology , vol.57 , Issue.7 , pp. 728-734
    • Athyros, V.G.1    Mikhailidis, D.P.2    Papageorgiou, A.A.3    Symeonidis, A.N.4    Pehlivanidis, A.N.5    Bouloukos, V.I.6    Elisaf, M.7
  • 21
    • 38449119409 scopus 로고    scopus 로고
    • Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
    • Treating to New Targets Investigators
    • Shepherd J, Kastelein JJ, Bittner V, et al.; Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2007; 2: 1131-9.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 1131-1139
    • Shepherd, J.1    Kastelein, J.J.2    Bittner, V.3
  • 22
    • 79960430739 scopus 로고    scopus 로고
    • Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome A post hoc analysis of the ATTEMPT study
    • the Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group
    • Athyros VG, Karagiannis A, Ganotakis ES, et al.; the Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 2011; 27: 1659-68.
    • (2011) Curr Med Res Opin , vol.27 , pp. 1659-1668
    • Athyros, V.G.1    Karagiannis, A.2    Ganotakis, E.S.3
  • 23
    • 84855392114 scopus 로고    scopus 로고
    • IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
    • IMPERATIVE Collaborative Group
    • Athyros VG, Hatzitolios AI, Karagiannis A, et al.; IMPERATIVE Collaborative Group. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci 2011; 7: 984-92.
    • (2011) Arch Med Sci , vol.7 , pp. 984-992
    • Athyros, V.G.1    Hatzitolios, A.I.2    Karagiannis, A.3
  • 26
    • 80052554967 scopus 로고    scopus 로고
    • Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate
    • Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Iaina-Levin N, Kobus G, Dobrzycki S. Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate. Arch Med Sci 2011; 7: 658-64.
    • (2011) Arch Med Sci , vol.7 , pp. 658-664
    • Malyszko, J.1    Bachorzewska-Gajewska, H.2    Malyszko, J.3    Iaina-Levin, N.4    Kobus, G.5    Dobrzycki, S.6
  • 27
    • 85047692424 scopus 로고
    • Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia
    • Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973; 132: 401-10.
    • (1973) Arch Intern Med , vol.132 , pp. 401-410
    • Klein, R.1    Klein, B.E.2    Cornoni, J.C.3    Maready, J.4    Cassel, J.C.5    Tyroler, H.A.6
  • 28
    • 0033529386 scopus 로고    scopus 로고
    • Serum uric acid and risk for cardiovascular disease and death: The Framingham heart study
    • Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 1999; 131: 7-13. (Pubitemid 29310011)
    • (1999) Annals of Internal Medicine , vol.131 , Issue.1 , pp. 7-13
    • Culleton, B.F.1    Larson, M.G.2    Kannel, W.B.3    Levy, D.4
  • 29
    • 0034630917 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
    • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10. (Pubitemid 30257539)
    • (2000) Journal of the American Medical Association , vol.283 , Issue.18 , pp. 2404-2410
    • Fang, J.1    Alderman, M.H.2
  • 30
    • 39749157632 scopus 로고    scopus 로고
    • Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study
    • DOI 10.1002/art.23121
    • Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology infor mation system (PreCIS) database cohort study. Arthritis Rheum 2008; 58: 623-30. (Pubitemid 351294901)
    • (2008) Arthritis and Rheumatism , vol.58 , Issue.2 , pp. 623-630
    • Ioachimescu, A.G.1    Brennan, D.M.2    Hoar, B.M.3    Hazen, S.L.4    Hoogwerf, B.J.5
  • 31
    • 62549112964 scopus 로고    scopus 로고
    • Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study
    • Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61: 225-32.
    • (2009) Arthritis Rheum , vol.61 , pp. 225-232
    • Chen, J.H.1    Chuang, S.Y.2    Chen, H.J.3    Yeh, W.T.4    Pan, W.H.5
  • 33
    • 79960411842 scopus 로고    scopus 로고
    • Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): A relationship with implications for vascular risk?
    • Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? Curr Vasc Pharmacol 2011; 9: 698-705.
    • (2011) Curr Vasc Pharmacol , vol.9 , pp. 698-705
    • Katsiki, N.1    Athyros, V.G.2    Karagiannis, A.3    Mikhailidis, D.P.4
  • 37
    • 84873704608 scopus 로고    scopus 로고
    • Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?
    • Epub ahead of print
    • Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease? Clin Cardiol 2013 Epub ahead of print.
    • (2013) Clin Cardiol
    • Eisen, A.1    Benderly, M.2    Goldbourt, U.3    Haim, M.4
  • 38
    • 65649116888 scopus 로고    scopus 로고
    • Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: Sub-analysis of the Japanese Coronary Artery Disease (JCAD) Study
    • Japanese Coronary Artery Disease Study Investigators
    • Okura T, Higaki J, Kurata M, et al.; Japanese Coronary Artery Disease Study Investigators. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: sub-analysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 2009; 73: 885-91.
    • (2009) Circ J , vol.73 , pp. 885-891
    • Okura, T.1    Higaki, J.2    Kurata, M.3
  • 39
    • 1542268611 scopus 로고    scopus 로고
    • Effect of Statins Versus Untreated Dyslipidemia on Serum Uric Acid Levels in Patients with Coronary Heart Disease: A Subgroup Analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
    • DOI 10.1053/j.ajkd.2003.12.023
    • Athyros VG, Elisaf M, Papageorgiou AA, et al.; GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004; 43: 589-99. (Pubitemid 38401873)
    • (2004) American Journal of Kidney Diseases , vol.43 , Issue.4 , pp. 589-599
    • Athyros, V.G.1    Elisaf, M.2    Papageorgiou, A.A.3    Symeonidis, A.N.4    Pehlivanidis, A.N.5    Bouloukos, V.I.6    Milionis, H.J.7    Mikhailidis, D.P.8
  • 41
    • 34547732002 scopus 로고    scopus 로고
    • GI epidemiology: Nonalcoholic fatty liver disease
    • Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-9.
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 883-889
    • Angulo, P.1
  • 42
    • 33747517955 scopus 로고    scopus 로고
    • The epidemiology of nonalcoholic fatty liver disease in adults
    • Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40 (Suppl 1): S5-10.
    • (2006) J Clin Gastroenterol , vol.40 , Issue.SUPPL. 1
    • Clark, J.M.1
  • 43
    • 84869224505 scopus 로고    scopus 로고
    • Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study
    • Koehler EM, Schouten JN, Hansen BE, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012; 57: 1305-11.
    • (2012) J Hepatol , vol.57 , pp. 1305-1311
    • Koehler, E.M.1    Schouten, J.N.2    Hansen, B.E.3
  • 44
    • 75449088414 scopus 로고    scopus 로고
    • Decreased survival of subjects with elevated liver function tests during a 28-follow-up
    • Söderberg C, Stå l P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-follow-up. Hepatology 2010; 51: 595-602.
    • (2010) Hepatology , vol.51 , pp. 595-602
    • Söderberg, C.1    Stå L, P.2    Askling, J.3
  • 46
    • 78649890465 scopus 로고    scopus 로고
    • Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
    • GREACE Study Collaborative Group
    • Athyros VG, Tziomalos K, Gossios TD, et al.; GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-22.
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3
  • 47
    • 81555203011 scopus 로고    scopus 로고
    • Safety and impact on cardiovascular events of long-term multi-factorial treatment in patients with metabolic syndrome and abnormal liver function tests: A post hoc analysis of the randomised ATTEMPT study
    • Athyros VG, Giouleme O, Ganotakis ES, et al. Safety and impact on cardiovascular events of long-term multi-factorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci 2011; 7: 796-805.
    • (2011) Arch Med Sci , vol.7 , pp. 796-805
    • Athyros, V.G.1    Giouleme, O.2    Ganotakis, E.S.3
  • 48
    • 84863987606 scopus 로고    scopus 로고
    • Smoking and non-alcoholic steatohepatitis (NASH): The GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial
    • Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial. J Hepatol 2012; 57: 476.
    • (2012) J Hepatol , vol.57 , pp. 476
    • Katsiki, N.1    Athyros, V.G.2    Karagiannis, A.3    Mikhailidis, D.P.4
  • 51
    • 79953880237 scopus 로고    scopus 로고
    • Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
    • Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011; 43: 167-71.
    • (2011) Ann Med , vol.43 , pp. 167-171
    • Athyros, V.G.1    Tziomalos, K.2    Daskalopoulos, G.N.3    Karagiannis, A.4    Mikhailidis, D.P.5
  • 53
    • 84857132090 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease in type 2 diabetes: Pathogenesis and treatment options
    • Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol 2012; 10: 162-72.
    • (2012) Curr Vasc Pharmacol , vol.10 , pp. 162-172
    • Tziomalos, K.1    Athyros, V.G.2    Karagiannis, A.3
  • 54
    • 84861869259 scopus 로고    scopus 로고
    • Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: A post hoc ATTEMPT analysis
    • Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group
    • Athyros VG, Elisaf MS, Alexandrides T, et al. Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology 2012; 63; 358-66.
    • (2012) Angiology , vol.63 , pp. 358-366
    • Athyros, V.G.1    Elisaf, M.S.2    Alexandrides, T.3
  • 55
    • 84865147415 scopus 로고    scopus 로고
    • Pharmacotherapy: Statins and new-onset diabetes mellitus: A matter for debate
    • Athyros VG, Mikhailidis DP. Pharmacotherapy: statins and new-onset diabetes mellitus: a matter for debate. Nat Rev Endocrinol 2012; 8: 133-4.
    • (2012) Nat Rev Endocrinol , vol.8 , pp. 133-134
    • Athyros, V.G.1    Mikhailidis, D.P.2
  • 56
    • 84871014821 scopus 로고    scopus 로고
    • Patient with hyper triglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 fatty acid ethyl esters
    • Athyros VG, Mikhailidis DP. Patient with hyper triglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 fatty acid ethyl esters. Open Cardiovasc Med J 2012; 6: 122-5.
    • (2012) Open Cardiovasc Med J , vol.6 , pp. 122-125
    • Athyros, V.G.1    Mikhailidis, D.P.2
  • 57
    • 82855161011 scopus 로고    scopus 로고
    • Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: The case for residual risk reduction after statin treatment
    • Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. Open Cardiovasc Med J 2011; 5: 24-34.
    • (2011) Open Cardiovasc Med J , vol.5 , pp. 24-34
    • Athyros, V.G.1    Tziomalos, K.2    Karagiannis, A.3    Mikhailidis, D.P.4
  • 59
  • 60
    • 84876745686 scopus 로고    scopus 로고
    • The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: A post hoc analysis of the GREACE Study
    • the GREACE Study Collaborative Group Epub ahead of print
    • Athyros VG, Tziomalos K, Katsiki N, et al.; the GREACE Study Collaborative Group. The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE Study. Curr Vasc Pharmacol 2012 Epub ahead of print.
    • (2012) Curr Vasc Pharmacol
    • Athyros, V.G.1    Tziomalos, K.2    Katsiki, N.3
  • 61
    • 0034829791 scopus 로고    scopus 로고
    • Smoking diminishes the beneficial effect of statins: Observations from the landmark trials
    • Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology 2001; 52: 575-87. (Pubitemid 32880107)
    • (2001) Angiology , vol.52 , Issue.9 , pp. 575-587
    • Milionis, H.J.1    Rizos, E.2    Mikhailidis, D.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.